Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SERM or Bisphosphonates After Denosumab in Osteoporosis
NCT03755193Phase 2Recruiting
- Sponsor
- Shinshu University
- Start
- Nov 2018
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of bazedoxifene in osteoporosis (3 arms), sponsored by Shinshu University. Primary endpoint: Bone Mineral Density at 2 years. Started Nov 2018; status: recruiting.
02
Drugs
bazedoxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03755193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03755193.